Compounds > acamprosate

Page last updated: 2024-08-25

acamprosate and Addiction, Opioid

acamprosate has been researched along with Addiction, Opioid in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	3 (37.50)	29.6817
2010's	3 (37.50)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Hulme, J; Sheikh, H; Wiercigroch, D	1
Binswanger, IA; Fazel, S; Hellner, C; Larsson, H; Molero, Y; Zetterqvist, J	1
Chalk, M; Lubran, R; Mark, TL; McCance-Katz, EF; Richardson, J	1
Crits-Christoph, P; Gallop, R; Gastfriend, DR; Gibbons, MB; Lundy, C; Markell, HM; Stringer, M	1
Kassed, CA; Kranzler, HR; Levit, KR; Mark, TL; Vandivort-Warren, R	1
Cador, M; Koob, GF; Stinus, L; Zorrilla, EP	1
Herzig, V; Schmidt, WJ	1
Litten, RZ	1

Other Studies

8 other study(ies) available for acamprosate and Addiction, Opioid

Article	Year
A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use. Substance abuse treatment, prevention, and policy, 2020, 01-13, Volume: 15, Issue:1 Topics: Acamprosate; Addiction Medicine; Adult; Aged; Alcohol Deterrents; Alcoholism; Buprenorphine; Emergency Service, Hospital; Female; Gabapentin; Humans; Male; Middle Aged; Naltrexone; Ontario; Opioid-Related Disorders; Patient Acceptance of Health Care; Primary Health Care; Referral and Consultation; Socioeconomic Factors; Substance Abuse Treatment Centers; Substance-Related Disorders; Time Factors; Young Adult	2020
Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime. The American journal of psychiatry, 2018, 10-01, Volume: 175, Issue:10 Topics: Acamprosate; Adult; Aged; Alcohol Deterrents; Alcoholism; Buprenorphine; Cohort Studies; Crime; Drug Overdose; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors; Suicidal Ideation; Young Adult	2018
Medicaid coverage of medications to treat alcohol and opioid dependence. Journal of substance abuse treatment, 2015, Volume: 55 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Buprenorphine, Naloxone Drug Combination; Humans; Insurance Coverage; Medicaid; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Taurine; United States	2015
A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri. Journal of substance abuse treatment, 2016, Volume: 70 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol-Related Disorders; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Missouri; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Outcome Assessment, Health Care; Psychotherapy; Taurine	2016
Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug and alcohol dependence, 2009, Jan-01, Volume: 99, Issue:1-3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Delayed-Action Preparations; Disulfiram; Drug Costs; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Humans; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Osteopathic Medicine; Physicians; Physicians, Family; Psychiatry; Taurine; United States	2009
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:1 Topics: Acamprosate; Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Avoidance Learning; Buprenorphine; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Implants; Fluoxetine; Lisuride; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome; Taurine	2005
Repeated-testing of place preference expression for evaluation of anti-craving-drug effects. Amino acids, 2005, Volume: 28, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Analgesics, Opioid; Anesthetics, Local; Animals; Behavior, Animal; Cocaine; Conditioning, Psychological; Drug Evaluation, Preclinical; Male; Morphine; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Taurine	2005
International update: new findings on promising medications. Alcoholism, clinical and experimental research, 1996, Volume: 20, Issue:8 Suppl Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Clinical Trials as Topic; Cocaine; Comorbidity; Europe; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Taurine; United States	1996